|
|
 |
| Авторизация |
|
|
|
| Поиск по указателям |
|
|
|
|
|
|
|
 |
|
|
|
| Carlson N.R. — Physiology of Behavior |
|
|
|
| Предметный указатель |
Meninges 67 68
Meninges, layers of 67f 68
Menstrual cycle 312
Menstrual cycle, and aggressiveness 367
Menstrual cycle, neuroendocrine control of 312—313 313f
Menstrual cycle, synchronization of 319
Mercaptoacetate (MA) 398
Mercer J.G. 411
Meredith M. 317
Mereu G. 597
Merkel's disk 222 222f 223f
Mesencephalic locomotor region 267—268
Mesencephalon 72 73f 73f 85—86 87f
Mesocortical system 114 115f 458
Mesolimbic system 113 458 459—460
Mesolimbic system, and schizophrenia symptoms 531
Mesolimbic system, cocaine use and 595
Mesopontine reticular formation 289
Messenger ribonucleic acid (mRNA) 30—31
Messenger ribonucleic acid (mRNA), in protein synthesis 31 32f
Mesulam M.-M. 461 513
Metabolic activity of brain, recording of 146—148 147f 148f 149f
Metabolic activity of brain, sleep deprivation and changes in 278
Metabolism 393—396
Metabolism, absorptive phase of 395f 396 397
Metabolism, effect of leptin on 404
Metabolism, efficiency of, differences in 415
Metabolism, fasting phase of 394 395 395f
Metabolism, peptide neurotransmitters involved in 421f—422f
Metabotropic glutamate receptor 121
Metabotropic receptors 54 55f 55—56
Metcalf D. 288
Metencephalon 72 73f 73t 86—88
Meterissian G. 559
Methadone maintenance 606
Method acting 356
Methyl palmoxirate (MP) 398
Methylene blue 137
Methylphenidate (Ritalin) 115
Methylphenidate (Ritalin), and schizophrenia symptoms 530
Methylphenidate (Ritalin), for narcolepsy 294
Metter E.J. 499
Meyer J.S. 109
Meyer T. 437
Meyer W.J. 368
Meyer-Bahlburg H.E. 322
MFB See Medial forebrain bundle
MGm 450
MGm, in conditioned emotional response 450—451 451f
Micevych P.E. 329
Michael R.P. 314
Microdialysis 149 149f
Microelectrode(s) 40 40f 41f 145
Microelectrode(s), construction of 145 145f
Microelectrode(s), recording of neural activity with 145—146 146f
Microglia 37
Microiontophoresis 151 152f
Micrometer (mm) 36
Micropipette, multibarreled 151 152f
Microscopy, electron 137—138 138f
Microscopy, two-photon laser scanning 432 435f
Microtome 136—137 137f
Micturition 375
Miczek K.A. 364 368—369
Midbrain 85—86 87f See
Middle cerebral artery 69f
Middle ear 202
Middle ear, evolution of 15 16f
Midsagittal plane 66 67
Miele L. 367
Miezin F.M. 193
Mikulincer M. 574
Milk production 333
Miller E.K. 445 447
Miller M.T. 567
Miller N.E. 20
Miller R. 446
Miller W.M. 487
Miller, Neal 457
Milner A.D. 197—198
Milner B. 468—471
Milner P. 457
Milner, Peter 457
Minard A. 279
Mind-body question 2
Mindus P. 563
Mineralocorticoid 570
Mirmiran M. 280
Mirror neurons 194 196 511
Mirror-drawing task 471 471f
Miselis R.R. 331 384
Miserendino M.J. 451—452
Mishkin M. 184 187 196—197 442 488
Mitchell J.E. 420
Mitchison G. 279
Mitler M.M. 294
Mitochondria 31f 31—32
Mitral cells 236—237 238f
Mitsuno K. 489
Miyashita Y. 488 489
Miyauchi S. 275
Mizoguchi K. 573
MK-801 542
MK-869, effects on depression 550 550f
Moclobemide 118 119
Moclobemide, effect on noradrenergic synapses 119f
Model (scientific) 9
Modesto-Lowe W. 608
Mogenson G.J. 387—388
Moghaddam B. 459 593
Mohr J.P. 471 492
Mok D. 387
Moldin S.O. 544
Molecules, diffusion of 42
Molinari M. 502
Mollon J.D. 172
Moltz H. 335
Mombaerts P. 238
Monaghan D.T. 440
Mondragon M. 319
Money J. 308 321—322 324—325 328
Monism 2
Moniz, Egas 347—348
Monoamine hypothesis, of depression 547—550
Monoamine oxidase (MAO) 115 116
Monoamine oxidase (MAO) inhibitors 545 549
Monoamine oxidase (MAO), in dopaminergic terminal buttons 116f
Monoamine(s) 113—121 See
Monosodium glutamate (MSG), taste of 233
Monosynaptic stretch reflex 247—249 248 248f 251
Monosynaptic stretch reflex, role in postural control 249 249f
Monozygotic (identical) twins 158
Monozygotic (identical) twins, dichorionic 538 538f
Monozygotic (identical) twins, discordance for schizophrenia in 537—538
Monozygotic (identical) twins, monochorionic 538 538f
Montague C.T. 416
Montero S. 570
Monti-Bloch L. 319
Mood disorders 544—555
Mood, REM sleep and 552
Mood, sleep deprivation and 553—554
Mook D. 390
Moore R.M. 279 288 295 297—298 301 328
Moore-Ede M.C. 302
Moore-GiUon M.J. 382
Mora R. 461
Morales F.R. 290
Moran T.H. 403
Morgan S. 337
Mori T. 501
| Morin L.P. 301
Morley J.E. 410
Morphine, dose-response curve for 102f
Morphine, effects of 97 101
Morphine, vs. aspirin 102
Morphine, vs. heroin 100 585
Morris J.S. 355
Morris N.M. 320—321
Morris R. 368
Morris R.G. 438 484
Morse J.R. 234—235
Morton J. 565
Moscovitch M. 191 357 443
Moss R.L. 318
Motion sickness 220
Motivation, brain structures responsible for 81
Motor association cortex 80f 80—81 See
Motor cortex See also Motor association cortex; Primary motor cortex
Motor cortex, organization of 252—254
Motor endplate 245
Motor homunculus 253f
Motor learning 426—427 427f
Motor learning, neural pathways involved in 452—457
Motor memories, in Broca's area 499
Motor neurons 27
Motor neurons, alpha 243 244 244f 249 250
Motor neurons, gamma 244 244f 249—250
Motor pathways 254—257 2581
Motor pathways, lateral group 254—256 256f
Motor pathways, ventromedial group 254 256—257 257f
Motor unit 244
Motta W. 591
Mountcastle W.B. 225 259
Mounting medium 137
Mountjoy K.G. 417
Mouth, satiety receptors in 388—389 389f
Movement, control of 242—268
Movement, control of, basal ganglia and 260—265
Movement, control of, brain structures responsible for 82 251—268
Movement, control of, cerebellar 265—267 266f 267f
Movement, control of, cortical 254f 254—257
Movement, control of, reflex 247—251
Movement, control of, reticular formation and 267—268
Movement, perception of 193—196
MP See Methyl palmoxirate
MPA See Medial preoptic area
MPRF See Medial pontine reticular formation
MPTP 263
MRI See Magnetic resonance imaging
mRNA See Messenger ribonucleic acid
Mrosovsky N. 298
MSG See Monosodium glutamate
MST region 193—194
Mucha R.F. 591
Mukhametov L.M. 276 282
Muller D. 435
Muller, Johannes 9—10 10f
Mullerian system 306 307f
Mullerian system, development of 307 308
Multibarreled micropipette 151 152f
Multipolar neurons 28 28f 29
Multiunit smooth muscle 246
Munro J.F. 418
Murdoch D. 364
Murison R. 342
Murphy A.Z. 329
Murphy J.M. 605
Murphy P.J. 283
Murray A.M. 533
Murray E.A. 488
Murray R. 530
Murray S. 368
Muscarine 112
Muscarine, effect on acetylcholinergic synapses 112f
Muscarinic receptors 112 113
Muscimol 124
Muscle spindles 243 244f
Muscle spindles, efferent control of 249
Muscle(s) 243—247
Muscle(s), antigravity 243
Muscle(s), cardiac 246
Muscle(s), contraction of 245 245f
Muscle(s), facial, feedback from 360
Muscle(s), paralysis of, during REM sleep 273 274 290 294
Muscle(s), sensory feedback from 245—246 247f
Muscle(s), skeletal 243—246 244f
Muscle(s), smooth 246
Museo G. 597
Mushiake H. 456
Mutations 13f 13—14
Mutations, of extra gene 76
Mutations, targeted 159
Mutism, akinetic 350
Muzio I.N. 279—280
Myasthenia gravis 111
Myelencephalon 72 73 73t 88
Myelin sheath 28 28f 36
Myelin sheath, advantages of 48
Myelin sheath, conduction of action potential in 47—48 49f
Myelin sheath, formation of 36—37 37f
Myers M.P. 301
Myers R.D. 410 606
Myofibril 244
myosin 244
Myosin cross bridges 244 245 245f
Myosin filaments, in auditory cilia 205 207 209f
Myosin filaments, in muscle contraction 244 245f
Myosin filaments, in muscle fiber 244f
Nadeau S.E. 500
Nader M.A. 589
Naeser M.A. 499
Nafe J.P. 223
Nagatani S. 310
Nair S.M. 572
Nakahara D. 459
Nakamura J. 226
Nakamura T. 237
Nakano I. 448
Naloxone 126 127 593
Naloxone, and placebo effect 103 103f
Naloxone, in addiction therapy 606—607
Naloxone, with electroconvulsive therapy 546
Naltrexone 601
Naltrexone, in addiction therapy 606—608 608f
Nambu T. 409
Naranjo C.A. 607
Narayan S.S. 212
Narcolepsy 293—294
Nath R. 228
Nathan R.S. 560
Nathans J. 173
Natural killer cells 577
Natural selection 13—14
Nauru islanders, obesity in 415—416
Nauta W.J. 234 286
Navigational tasks 482—487
ne See Norepinephrine
Neale J.M. 560 579
Neanderthals 16 17
Neat See Nonexercise activity thermogenesis
Ned J.V. 415
Nef P. 238
Negative afterimage 175 175f
Negative feedback 372 373
Negative reinforcement 586
Negative reinforcement, and drug addiction 586—587
Negative symptoms of schizophrenia 529 529f 534
Negative symptoms of schizophrenia, PCP abuse and 540—541
Negative symptoms of schizophrenia, relation with positive symptoms 539—542
Nelson J. 517
|
|
|
| Реклама |
|
|
|
|
|
О проекте